secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptose Biosciences Inc. (APTOF)
CIK:        0000882361
Form:       8-K
Filed at:   2023-05-23T23:59:59+00:00
Accession:  0001171843-23-003527
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptose shareholders approve 1-for-15 reverse stock split; board implements immediately
--------------------------------------------------------------------------------

- 93.44% of votes cast approved reverse stock split at ratio of 15 pre-split shares to 1 post-split share.
- Board implemented split immediately post-meeting; articles expected filed May 24, 2023.
- Current 93,961,581 common shares to reduce to approx. 6,264,105, no fractional shares issued.
- All seven director nominees elected; KPMG re-appointed as auditor; stock plan amendment approved.
- Shareholder votes also approved adjournment proposal and non-binding executive compensation resolution.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882361/000117184323003527/0001171843-23-003527-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882361/000117184323003527/f8k_052323.htm
  HTML page:      https://secwatch.observer/filing/0001171843-23-003527

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer